| Literature DB >> 27259338 |
J E MacLean1, K DeHaan2, D Fuhr3, S Hariharan1, B Kamstra1, L Hendson4, I Adatia1, C Majaesic2, A T Lovering5, R B Thompson6, D Nicholas7, B Thebaud8, M K Stickland9.
Abstract
BACKGROUND: Extreme preterm birth confers risk of long-term impairments in lung function and exercise capacity. There are limited data on the factors contributing to exercise limitation following extreme preterm birth. This study examined respiratory mechanics and ventilatory response during exercise in a large cohort of children born extremely preterm (EP).Entities:
Keywords: Exercise; Lung Physiology; Paediatric Lung Disaese
Mesh:
Year: 2016 PMID: 27259338 PMCID: PMC5099182 DOI: 10.1136/thoraxjnl-2015-207736
Source DB: PubMed Journal: Thorax ISSN: 0040-6376 Impact factor: 9.139
Figure 1Distribution of extremely preterm eligible and enrolled children as well as control children. The number of children successfully completing each activity day measure is shown. More children with mod/sev BPD were unable to complete lung volume (20% vs 5.7% vs 1.5%, p<0.01), diffusion capacity (26% vs 3.8% vs 4.6.%, p<0.001) and CPET (14% vs 1.9% vs 4.6%, p<0.05). BPD, bronchopulmonary dysplasia; CPET, cardiopulmonary exercise testing; mod/sev, moderate/severe.
Perinatal data for children born extremely preterm
| Moderate/severe BPD (mean±SD; n(%)) | No/mild BPD (mean±SD; n(%)) | |
|---|---|---|
| n | 47 | 53 |
| Gestational age (weeks)* | 26.0±1.9 | 26.7±1.1 |
| Birth weight (g)‡ | 813±191 | 982±163 |
| Maternal age (years) | 29.6±5.8 | 30.3±6.3 |
| Doses of surfactant† | 2.3±2.1 | 1.1±1.8 |
| Days of initial ventilation‡ | 29±22 | 6±11 |
| NICU LOS (days)‡ | 104±32 | 65±28 |
| PROM | 10 (21%) | 7 (13%) |
| Antenatal corticosteroids | 33 (70%) | 43 (83%) |
| Clinical chorioamnionitis | 3 (6%) | 4 (8%) |
| Caesarean section* | 34 (72%) | 27 (52%) |
| RDS | 45 (98%) | 51 (98%) |
| PDA requiring surgery* | 12 (27%) | 5 (10%) |
| Postnatal corticosteroids* | 13 (28%) | 3 (6%) |
*p<0.05; †p<0.01; ‡p<0.001.
BPD, bronchopulmonary dysplasia; NICU LOS, neonatal intensive care unit length of stay; PDA, patent ductus arteriosus; PROM, premature rupture of membranes >24 h prior to delivery; RDS, respiratory distress syndrome.
Demographics at follow-up for extremely preterm and control children
| Mod/sev BPD (mean±SD, n (%)) | No/mild BPD (mean±SD, n (%)) | Control (mean±SD, n (%)) | |
|---|---|---|---|
| n | 47 | 53 | 64 |
| Age (years) | 11.9±1.6 | 12.3±1.5 | 11.6±1.9 |
| Height z-score‡ | −0.27±0.98 | −0.07±1.05 | 0.45±0.88 |
| Weight z-score‡ | −0.074±1.28 | −0.39±0.99 | 0.45±0.85 |
| BMI z-score† | 0.074±1.24 | −0.42±1.01 | 0.33±1.04 |
| % Male | 27 (57%) | 34 (64%) | 37 (58%) |
| % Caucasian | 34 (79%) | 40 (82%) | 45 (82%) |
| Maternal smoking in pregnancy | 11 (24%) | 10 (19%) | 7 (12%) |
| Household cigarette smoke exposure | 15 (32%) | 16 (31%) | 12 (20%) |
| Asthma* | 18 (38%) | 16 (30%) | 11 (17%) |
| Wheeze in last 12 months* | 19 (40%) | 13 (24%) | 9 (15%) |
| Asthma medications in last 12 months | 10 (21%) | 7 (13%) | 4 (6%) |
| Activity more than average† | 15 (32%) | 27 (51%) | 37 (63%) |
| SOB with activity† | 18 (38%) | 8 (15%) | 9 (15%) |
Post hoc ANOVA one-way comparisons (mean±SE):
Height z-score: mod/sev BPD 0.72±0.19
Weight z-score: mod/sev BPD 0.52±0.20
BMI z-score: no/mild BPD 0.75±0.20
*p<0.05; †p<0.01; ‡p<0.001.
ANOVA, analysis of variance; BMI, body mass index; BPD, bronchopulmonary dysplasia; mod/sev, moderate/severe; SOB, shortness of breath.
Lung function tests comparing extremely preterm and control children
| Differences from control | |||||
|---|---|---|---|---|---|
| Mod/sev BPD (mean±SD) | No/mild BPD (mean±SD) | Control (mean±SD) | Mod/sev BPD (mean (95% CI)) | No/mild BPD (mean (95% CI)) | |
| zFEV1‡ | −0.92±1.36 | −0.50±1.10 | 0.09±1.01 | −1.00 (−1.54 to −0.47)† | −0.58 (−1.10 to −0.068)* |
| zFVC | −0.85±1.67 | 0.35±1.25 | 0.47±0.90 | ||
| zFEV1/FVC† | −1.14±1.5 | −1.3±0.80 | −0.57±1.14 | −0.56 (−1.11 to −0.015)† | −0.71 (−1.25 to −0.19)† |
| zFEF25–75‡ | −1.6±1.22 | −1.3±0.87 | −0.48±1.12 | −1.09 (−1.59 to −0.58)‡ | −0.84 (−1.33 to −0.35)‡ |
| zTLC | 0.63±1.08 | 0.66±1.10 | 0.38±1.02 | ||
| zRV* | 0.092±1.12 | −0.16±0.95 | −0.47±0.97 | 0.56 (0.70 to 1.06)* | |
| zRV/TLC† | −0.19±1.33 | −0.55±1.04 | −0.91±1.00 | 0.72 (0.18 to 1.27)† | |
| zFRC | 0.22±1.12 | 0.072±0.92 | −0.29±1.11 | ||
| zTLCO | −0.49±0.76 | −0.52±0.82 | −0.32±0.69 | ||
| zTLCO/VA† | −1.64±0.89 | −1.57±0.76 | −1.06±0.95 | −0.58 (−1.02 to −0.13)† | −0.50 (−0.91 to −0.10)† |
| MVV (L) | 79.5±27.5 | 83.3±27.9 | 93.1±30.7 | ||
*p<0.05; †p<0.01; ‡p<0.001.
BPD, bronchopulmonary dysplasia; FEF25–75, forced expiratory flow between 25–75% of FVC; FRC, functional residual capacity; mod/sev, moderate/severe; MVV, maximum voluntary ventilation; RV, residual volume; TLC, total lung capacity; TLCO, transfer factor for carbon monoxide; VA, alveolar volume; z, z-score.
Cardiopulmonary exercise test (CPET) cardiovascular responses at peak exercise comparing extremely preterm and control children
| Mod/sev BPD (mean±SD) | No/mild BPD (mean±SD) | Control (mean±SD) | |
|---|---|---|---|
| Exercise time (min:sec) | 6:52±2:01 | 8:33±2:12 | 7:45±1:39 |
| RQ | 1.07±0.086 | 1.07±0.84 | 1.07±0.081 |
| Heart rate (beats/min) | 175.8±14.9 | 178.1±19.1 | 182.5±15.5 |
| Work (W) | 89.2±32.4 | 104.5±33.2 | 109.6±35.8 |
| VO2peak (L/min) | 1.65±0.65 | 1.83±0.55 | 1.87±0.43 |
| VO2peak % predicted (%)† | 89.3±23.0 | 107.4±22.7 | 103.4±26.5 |
| VO2peak relative (mL/kg/min)† | 36.9±10.7 | 44.6±9.2 | 42.6±9.6 |
| VCO2peak (L/min)* | 1.71±0.62 | 1.98±0.65 | 2.03±0.49 |
Post hoc ANOVA one-way comparisons (mean±SE).
VO2peak relative: mod/sev BPD 5.73±1.94 L/min
VO2peak % predicted: mod/sev BPD 14±5%
VCO2 peak: No statistically significant one-way differences.
*p<0.05; †p<0.01.
ANOVA, analysis of variance; BPD, bronchopulmonary dysplasia; mod/sev, moderate/severe; RQ, respiratory quotient; VCO2peak, peak carbon dioxide uptake; VO2, oxygen uptake.
Cardiopulmonary exercise test (CPET) peak respiratory responses comparing extremely preterm (EP) children and control children
| Mod/sev BPD (mean±SD) | No/mild BPD (mean±SD) | Control (mean±SD) | |
|---|---|---|---|
| RR baseline (breaths/min)* | 23.0±4.6 | 20.2±4.7 | 20.6±5.2 |
| RR peak (breaths/min) | 48.0±12.8 | 46.9±10.9 | 47.5±12.4 |
| VT/kg baseline (mL/kg)* | 12.2±4.0 | 14.9±6.3 | 13.4±5.1 |
| VT/kg peak (mL/kg)† | 25.7±7.5 | 31.9±5.8 | 29.5±6.5 |
| VE/kg baseline (mL/kg/min) | 266±101 | 275±91 | 250±90 |
| VE/kg peak (mL/kg/min)* | 1393±428 | 1631±431 | 1433±378 |
| Inspiratory capacity baseline (L) | 1.75±0.56 | 1.74±0.74 | 1.67±0.58 |
| Inspiratory capacity peak (L) | 1.84±0.47 | 1.85±0.68 | 1.94±0.68 |
| SpO2 baseline (%) | 97.5±2.9 | 97.7±2.7 | 98.3±1.2 |
| SpO2 peak (%) | 94.3±4.9 | 95.2±4.7 | 95.3±4.9 |
| PETO2 peak (mm Hg) | 103.0±4.8 | 103.8±4.9 | 102.1±10.1 |
| PETCO2 peak (mm Hg) | 35.6±4.1 | 35.6±3.9 | 36.1±3.8 |
| VE/VO2 slope | 27.9±3.3 | 27.4±2.7 | 26.4±2.8 |
| VE/VCO2 slope* | 30.5±3.8 | 28.9±2.9 | 28.6±3.2 |
| BR (%)* | 18.5±23.6 | 15.5±20.9 | 24.6±16.9 |
| Expiratory flow limitation (n, %)* | 16/34 (47%) | 16/49 (33%) | 14/59 (24%) |
| End exercise—dyspnoea | 4.0±2.8 | 4.4±2.2 | 3.8±2.4 |
| End exercise—RPE | 6.0±2.5 | 5.6±2.4 | 5.0±2.7 |
*p<0.05.
†p<0.001.
Post hoc ANOVA one-way comparisons (mean±SE).
RR baseline: mod/sev BPD 2.8±1.0 breaths/min>no/mild BPD*.
VT/kg baseline: mod/sev BPD 2.7±1.1mL/kg
VT/kg peak: mod/sev BPD 6.2±1.4 mL/kg
VE/kg peak: mod/sev BPD 233±88 mL/kg/min
VE/VCO2 peak: mod/sev BPD 1.94±0.69
BR: no/mild BPD 9.0±3.8%
ANOVA, analysis of variance; BPD, bronchopulmonary dysplasia; BR, breathing reserve; mod/sev, moderate/severe, PETCO2, end tidal carbon dioxide tension; PETO2, end tidal oxygen tension; RPE, rating of perceived exertion; RR, respiratory rate; SpO2, oxygen saturation pulse; VCO2, carbon dioxide uptake; VE, minute ventilation; VO2, oxygen uptake; VT, tidal volume.
Predictors of exercise capacity as measured by VO2% predicted
| Variables | B±SE | Standardised coefficient | p Value |
|---|---|---|---|
| Group* | −17.21±6.02 | −0.56 | 0.005 |
| Male sex | −24.42±9.03 | −0.48 | 0.008 |
| Shortness of breath with activity | −9.63±4.01 | −0.16 | 0.018 |
| More active than average | 10.69±3.41 | 0.21 | 0.003 |
| Age | −3.19±0.95 | −0.22 | 0.001 |
| zBMI | −10.06±1.43 | −0.47 | <0.001 |
| Interaction: group×sex | 15.17±4.04 | 0.95 | <0.001 |
The R2 for the model is 0.43, p<0.001.
*Group: 1=mod/sev BPD, 2=no/mild BPD, 3=control.
BMI, body mass index; BPD, bronchopulmonary dysplasia; VO2, oxygen uptake; z, z-score.